NCT06808321Completed
Benidipine in Hypertensive and/or Chronic Coronary Syndrome Patients
Evaluation of Clinical Outcomes of Benidipine in Hypertensive and/or Chronic Coronary Syndrome Patients in the Turkish Population
Source: ClinicalTrials.gov · Last updated 4 Nov 2026
Brief summary (registry, in English)
Evaluation of the clinical outcomes of Benidipine initiated by physician's preference in patients with hypertension and/or angina pectoris (chronic coronary syndrome) presenting to cardiology outpatient clinics in Türkiye. This is a prospective, multicenter, observational registry and is strictly non-interventional. The decision to prescribe Benidipine is made by the treating physician as part of routine medical care, independent of and prior to study enrollment. No study-specific interventions, treatment assignments, or additional diagnostic procedures are mandated by the protocol. The study solely observes and records real-world clinical outcomes without any investigator interference in the standard management of the patient.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1659 (actual)
- First submitted
- 26 Jan 2025
- Start date
- 1 Mar 2025
- Primary completion date
- 1 Jan 2026
- Lead sponsor
- The Society of Prevention and Awareness of Cardiovascular Diseases
- NCT number
- NCT06808321
What you commit to
- Study type: Observational
- Participants enrolled: 1659
- From 1 Mar 2025 to the primary completion date, 1 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Having to take other medications during the study that may affect blood pressure
- Participation in other clinical trials within 3 months prior to this study
Other illness
- Patients with secondary hypertension
- Evidence of decompensated congestive heart failure, unstable angina or severe arrhythmia
Lab values
- Allergic to DHP calcium antagonists
Other
- Emergency hypertensive patients
- Severe renal or hepatic dysfunction
- Pregnant or lactating women
- Patients who did not sign the consent form of the study
Who the study is looking for
- Patients with hypertension and/or angina pectoris on the background of chronic coronary syndrome who have been receiving Benidipine treatment for at least 1 month and will continue to receive Benidipine treatment
- Male or female outpatients, 18-80 years of age
- Patients with mild to moderate essential hypertension who have been receiving or will continue Benidipine treatment for at least 1 month
- Outpatients with clinically stable angina pectoris and patients who have been receiving or will continue Benidipine treatment for at least 1 month
- Those who signed the written informed consent form
Age in the registry: 18 years to 80 years · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ege University Coordinator of this site? Confirm its status | Izmir | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.